TITLE

Medical biochemistry

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS47
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Nuchal tranlucency as a marker for the screening of Down syndrome: Establishment of reference values,' by J.C. Forest et al.
ACCESSION #
9708236422

 

Related Articles

  • Diagnosis of Down's syndrome at birth.  // British Medical Journal;10/9/1976, Vol. 2 Issue 6040, p835 

    Focuses on the problems in diagnosing Down's syndrome at birth. Signs and symptoms of the syndrome in babies; Prevalence of congenital heart lesions among children with the syndrome; Method to reduce the number of infants born with the syndrome.

  • Ethics of antenatal screening for Down's syndrome.  // Archives of Disease in Childhood;Jul2003, Vol. 88 Issue 7, p607 

    Reports that Great Britain National Screening Committee of the Department of Health is developing national standards for antenatal screening for Down's syndrome. Ethical aspects of the antenatal screening; Proposal to extend the screening to all women; Definition of acceptable false-positive rates.

  • Down Syndrome: Prenatal Risk Assessment and Diagnosis.  // American Family Physician;8/15/2000, Vol. 62 Issue 4, p825 

    Down syndrome (trisomy 21) is the most commonly recognized genetic cause of mental retardation. The risk of trisomy 21 is directly related to maternal age. All forms of prenatal testing for Down syndrome must be voluntary. A nondirective approach should be used when presenting patients with...

  • A case of: examining ectopia cordis. Trower, Laura // Synergy: Imaging & Therapy Practice;Jan2011, p10 

    The article presents a case study of a 35-year-old female Gravida 3 Para 1 who attended the antenatal department for her first trimester Combined Downs Syndrome screening assessment. Her obstetric history was unremarkable and she denied exposure to recreational drugs or having taken any...

  • NIPT: an issue to handle with care. Lancaster, Verity // British Journal of Midwifery;May2019, Vol. 27 Issue 5, p330 

    Verity Lancaster was named BJM Student Midwife of the Year for her work developing a care pathway for Down Syndrome in the ante- and postnatal periods. Here, she discusses diagnosis

  • Literature News.  // Contemporary OB/GYN;Nov99, Vol. 44 Issue 11, p112 

    Presents excerpts from literature pertaining to obstetrics and gynecology as of November 1999. Information on a prenatal screening for Down syndrome; Beneficial effects of treating breast cancer with tamoxifen; Evaluation on devices for managing urinary incontinence.

  • Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution. Spencer, K.; Carpenter, P. // British Medical Journal (Clinical Research Edition);6/29/1985, Vol. 290 Issue 6486, p1940 

    Investigates the efficacy of medical screening of Down's syndrome using serum alpha fetoprotein in Great Britain. Comparison of various screening strategies; Identification of pregnancies affected by the disease; Measurement of maternal serum alpha fetoproteins.

  • Maternal Serum Triple Analyte Screening in Pregnancy. Cate, Sara // American Family Physician;8/15/2000, Vol. 62 Issue 4, p738 

    Editorial. Emphasizes the importance of genetic screening for Down syndrome. Information on the triple analyte screening in pregnancy; Limitations of the test; Detection rate of the test.

  • The Genetic Sonogram Today: What is the Role of "Soft Markers" in the Prediction of Down Syndrome? CIGNINI, PIETRO; GULINO, FERDINANDO ANTONIO; VITALE, SALVATORE GIOVANNI; LAGANÀ, ANTONIO SIMONE; VALENTI, GAETANO; RAPISARDA, AGNESE MARIA CHIARA; SCARALE, MARIA GIOVANNA; LA ROSA, VALENTINA LUCIA; GIORLANDINO, CLAUDIO // Connecticut Medicine;Oct2017, Vol. 81 Issue 9, p537 

    Background: The aim of this study is to evaluate the role of "soft markers" in the prediction of Down syndrome (DS). Methods: This study includes an unselected population of 1999 pregnant women who requested a fetal karyotype test using amniocentesis at gestational ages ranging from 15 to 20...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics